Vax-Unvax: Let The Science Speak Home › Citations Chapter 11 This is a listing of all citations in this chapter. 1 Medicines Adverse Reactions Committee, “Use of Boostrix (Combined Diphtheria, Tetanus and Pertussis Vaccine) in Pregnancy: Confidential,” report (2020). 2 US Food and Drug Administration, Fluvirin®: Package Insert, (Summit, NJ: Seqirus USA Inc., Revised 2017). 3 US Food and Drug Administration, Comirnaty®: Package Insert, (New York, NY: Pfizer Inc., 2022). 4 US Food and Drug Administration, Spikevax®: Package Insert, (New York, NY: Moderna Inc., 2022). 5 “Pregnancy Guidelines and Recommendations by Vaccine,” Centers for Disease Control and Prevention, August 31, 2016. 6 “Covid-19 Vaccines While Pregnant or Breastfeeding,” Centers for Disease Control and Prevention, Updated June 16, 2022. 7 Centers for Disease Control and Prevention. (2021). “COVID-19 Vaccine Pregnancy Registry.” Vaccine Safety. Accessed May 3, 2023. 8 Ousseny Zerbo, et al., “Association Between Influenza Infection and Vaccination During Pregnancy and Risk of Autism Spectrum Disorder,” JAMA Pediatrics 171, no. 1 (2017): e163609, doi:10.1001/jamapediatrics.2016.3609. 9 Ousseny Zerbo, et al., “Association Between Influenza Infection and Vaccination During Pregnancy and Risk of Autism Spectrum Disorder,” JAMA Pediatrics 171, no. 1 (2017): e163609, doi:10.1001/jamapediatrics.2016.3609. 10 Ousseny Zerbo, et al., “Association Between Influenza Infection and Vaccination During Pregnancy and Risk of Autism Spectrum Disorder,” JAMA Pediatrics 171, no. 1 (2017): e163609, doi:10.1001/jamapediatrics.2016.3609. 11 Juliet Popper Shaffer, “Multiple Hypothesis Testing,” Annual Review of Psychology 46, (1995): 561-584. 12 Alberto Donzelli, Alessandro Schivalocchi, and Alessandro Battaggia, “Influenza Vaccination in the First Trimester of Pregnancy and Risk of Autism Spectrum Disorder,” JAMA Pediatrics 171, (2017): 601, doi:10.1001/jamapediatrics.2017.0753. 13 Brian S. Hooker, “Influenza Vaccination in the First Trimester of Pregnancy and Risk of Autism Spectrum Disorder,” JAMA Pediatrics 171, no. 6 (2007): 600, doi:10.1001/jamapediatrics.2017.0734. 14 Ousseny Zerbo, et al., “Association Between Influenza Infection and Vaccination During Pregnancy and Risk of Autism Spectrum Disorder,” JAMA Pediatrics 171, no. 1 (2017): e163609, doi:10.1001/jamapediatrics.2016.3609. 15 Ousseny Zerbo, et al., “Association Between Influenza Infection and Vaccination During Pregnancy and Risk of Autism Spectrum Disorder,” JAMA Pediatrics 171, no. 1 (2017): e163609, doi:10.1001/jamapediatrics.2016.3609. 16 Brian S. Hooker, “Influenza Vaccination in the First Trimester of Pregnancy and Risk of Autism Spectrum Disorder,” JAMA Pediatrics 171, no. 6 (2007): 600, doi:10.1001/jamapediatrics.2017.0734. 17 Stephanie A. Irving et al., “Trivalent Inactivated Influenza Vaccine and Spontaneous Abortion,” Obstetrics and Gynecology 121, no. 1 (2013): 159–165, doi:10.1097/aog.0b013e318279f56f. 18 Stephanie A. Irving et al., “Trivalent Inactivated Influenza Vaccine and Spontaneous Abortion,” Obstetrics and Gynecology 121, no. 1 (2013): 159–165, doi:10.1097/aog.0b013e318279f56f. 19 Stephanie A. Irving et al., “Trivalent Inactivated Influenza Vaccine and Spontaneous Abortion,” Obstetrics and Gynecology 121, no. 1 (2013): 159–165, doi:10.1097/aog.0b013e318279f56f. 20 James G. Donahue et al., “Association of Spontaneous Abortion with Receipt of Inactivated Influenza Vaccine Containing H1N1pdm09 in 2010-11 and 2011-12,” Vaccine 35, no. 40 (2017): 5314–5322, doi:10.1016/j.vaccine.2017.06.069. 21 James G. Donahue et al, “Inactivated Influenza Vaccine and Spontaneous Abortion in the Vaccine Safety Datalink in 2012-13, 2013-14, and 2014-15,” Vaccine 37, no.44 (2019): 6673–6681, doi:10.1016/j.vaccine.2019.09.035. 22 Stephanie A. Irving et al., “Trivalent Inactivated Influenza Vaccine and Spontaneous Abortion,” Obstetrics and Gynecology 121, no. 1 (2013): 159–165, doi:10.1097/aog.0b013e318279f56f. 23 Gary S. Goldman, “Comparison of VAERS Fetal-Loss Reports During Three Consecutive Influenza Seasons: Was There a Synergistic Fetal Toxicity Associated with the Two-Vaccine 2009/2010 Season?,” Human & Experimental Toxicology 32, no. 5 (2012) 464–475. https://doi.org/10.1177/0960327112455067. 24 Gary S. Goldman, “Comparison of VAERS Fetal-Loss Reports During Three Consecutive Influenza Seasons: Was There a Synergistic Fetal Toxicity Associated with the Two-Vaccine 2009/2010 Season?,” Human & Experimental Toxicology 32, no. 5 (2012) 464–475. https://doi.org/10.1177/0960327112455067. 25 Gary S. Goldman, “Comparison of VAERS Fetal-Loss Reports During Three Consecutive Influenza Seasons: Was There a Synergistic Fetal Toxicity Associated with the Two-Vaccine 2009/2010 Season?,” Human & Experimental Toxicology 32, no. 5 (2012) 464–475. https://doi.org/10.1177/0960327112455067. 26 Gary S. Goldman, “Comparison of VAERS Fetal-Loss Reports During Three Consecutive Influenza Seasons: Was There a Synergistic Fetal Toxicity Associated with the Two-Vaccine 2009/2010 Season?,” Human & Experimental Toxicology 32, no. 5 (2012) 464–475. https://doi.org/10.1177/0960327112455067. 27 Gary S. Goldman, “Comparison of VAERS Fetal-Loss Reports During Three Consecutive Influenza Seasons: Was There a Synergistic Fetal Toxicity Associated with the Two-Vaccine 2009/2010 Season?,” Human & Experimental Toxicology 32, no. 5 (2012) 464–475. https://doi.org/10.1177/0960327112455067. 28 Gary S. Goldman, “Comparison of VAERS Fetal-Loss Reports During Three Consecutive Influenza Seasons: Was There a Synergistic Fetal Toxicity Associated with the Two-Vaccine 2009/2010 Season?,” Human & Experimental Toxicology 32, no. 5 (2012) 464–475. https://doi.org/10.1177/0960327112455067. 29 James G. Donahue et al., “Association of Spontaneous Abortion with Receipt of Inactivated Influenza Vaccine Containing H1N1pdm09 in 2010-11 and 2011-12,” Vaccine 35, no. 40 (2017): 5314–5322, doi:10.1016/j.vaccine.2017.06.069. 30 James G. Donahue et al., “Association of Spontaneous Abortion with Receipt of Inactivated Influenza Vaccine Containing H1N1pdm09 in 2010-11 and 2011-12,” Vaccine 35, no. 40 (2017): 5314–5322, doi:10.1016/j.vaccine.2017.06.069. Page 1 of 41234»